Information:
Fel:
ID
22710
Beskrivning
Prospective Randomized Trial of Seminal Vesicle-Sparing Prostatectomy and Nerve-Sparing Radical Prostatectomy in Men With Clinically Localized Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01825642
Länk
https://clinicaltrials.gov/show/NCT01825642
Nyckelord
Versioner (1)
- 2017-06-10 2017-06-10 -
Uppladdad den
10 juni 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Prostate Cancer NCT01825642
Eligibility Prostate Cancer NCT01825642
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT01825642
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
gender, histologically confirmed adenocarcinoma of the prostate
Item
men with biopsy-proven histologic diagnosis of prostate adenocarcinoma
boolean
C0079399 (UMLS CUI [1])
C0679557 (UMLS CUI [2,1])
C0007112 (UMLS CUI [2,2])
C0679557 (UMLS CUI [2,1])
C0007112 (UMLS CUI [2,2])
low risk for seminal vesicle invasions
Item
low risk for seminal vesicle invasions defined by:
boolean
C3538919 (UMLS CUI [1,1])
C1718327 (UMLS CUI [1,2])
C1718327 (UMLS CUI [1,2])
clinical TNM stage, gleason, psa, positive prostate biopsy core proportion
Item
clinical stage t1c/tumor 2-node 0-metastasis 0, gleason score ≤ 6, psa ≤ 10 ng/ml, positive prostate biopsy core proportion ≤ 1/2 (50%) or clinical stage t1c/t2n0m0, gleason ≤ 7, psa ≤ 6 ng/ml, positive biopsy core proportion ≤ 1/3 (33.3%)
boolean
C1707417 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0201544 (UMLS CUI [3])
C0194804 (UMLS CUI [4,1])
C1446409 (UMLS CUI [4,2])
C0444669 (UMLS CUI [4,3])
C1709707 (UMLS CUI [4,4])
C3203027 (UMLS CUI [2])
C0201544 (UMLS CUI [3])
C0194804 (UMLS CUI [4,1])
C1446409 (UMLS CUI [4,2])
C0444669 (UMLS CUI [4,3])
C1709707 (UMLS CUI [4,4])
international index of erectile function score
Item
sexually potent, defined as international index of erectile function score ≥ 21, prior to randomization and surgery
boolean
C2959364 (UMLS CUI [1])
informed consent
Item
competent to provide informed consent
boolean
C0021430 (UMLS CUI [1])
english
Item
able to read and write english
boolean
C0376245 (UMLS CUI [1])
bilateral nerve-sparing
Item
candidate for bilateral nerve-sparing
boolean
C0444743 (UMLS CUI [1])
compliance follow-up
Item
willing to be followed for 12 months post-surgery
boolean
C1321605 (UMLS CUI [1,1])
C1522577 (UMLS CUI [1,2])
C1522577 (UMLS CUI [1,2])
intermediate or high risk for seminal vesicle invasion
Item
intermediate or high risk for seminal vesicle invasion
boolean
C3640764 (UMLS CUI [1,1])
C0332167 (UMLS CUI [1,2])
C1718327 (UMLS CUI [1,3])
C0332167 (UMLS CUI [1,2])
C1718327 (UMLS CUI [1,3])
unwilling to be randomized
Item
unwilling to be randomized to either treatment arm
boolean
C0558080 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
C0034656 (UMLS CUI [1,2])
pre-operative treatment with radiation and/or hormone therapy
Item
pre-operative treatment with radiation and/or hormone therapy
boolean
C0279134 (UMLS CUI [1])
C1514460 (UMLS CUI [2])
C1514460 (UMLS CUI [2])
planned adjuvant radiation and/or hormonal therapy
Item
planned adjuvant radiation and/or hormonal therapy
boolean
C1301732 (UMLS CUI [1,1])
C1706721 (UMLS CUI [1,2])
C1301732 (UMLS CUI [2,1])
C1971498 (UMLS CUI [2,2])
C1706721 (UMLS CUI [1,2])
C1301732 (UMLS CUI [2,1])
C1971498 (UMLS CUI [2,2])